Biotechnology News

October 13, 2014

PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--VGTI Florida launches its new Center for Diseases of Aging in collaboration with Sweden's Karolinska Institute, perhaps best known for annually awarding the Nobel Prize in Medicine.

October 13, 2014

MILAN--(BUSINESS WIRE)--Sorin Group announces results of the Perceval CAVALIER Trial and the Pooled European Multicenter Experience at the 28th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS).

October 13, 2014

SAN DIEGO--(BUSINESS WIRE)--Cosmederm Bioscience has announced that UK-based Woodford Investment Management is investing $50 million into the company.

October 13, 2014

PARIS--(BUSINESS WIRE)--Stem cells hold great promise for treating a variety of human diseases and injuries. Basic and translational stem cell research is among the most competitive fields in the life sciences. We have co-organized the first...

October 13, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call

October 13, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. today announced the New Drug Application (NDA) for palbociclib has been accepted for filing and granted Priority Review by the United States Food and Drug Administration (FDA). This NDA requests FDA approval...

October 13, 2014

NEW YORK & SUNNYVALE, Calif. & RARITAN, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb, Pharmacyclics and Janssen Announce Clinical Collaboration to Evaluate OPDIVO® (nivolumab) and IMBRUVICA®(ibrutinib) in Non-Hodgkin Lymphoma

October 13, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Concert presented CTP-354 Phase 1 clinical results at the American Neurological Association Annual Meeting. CTP-354 is a potential treatment for spasticity.

October 13, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, announced today six-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran (ALN-TTR02), an...

October 13, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd. announced that ‘The Giant Salamander Glycopeptides in Resisting Skin Photo-aging Clinical Research’ has been published in ‘Chinese Medical Cosmetology’ Periodical (Volume 4, Issue 3, 2014...

October 13, 2014

TOULOUSE, France--(BUSINESS WIRE)--Regulatory News: VEXIM (Paris:ALVXM) (FR0011072602 – ALVXM / Eligible PEA-PME), a medical device company specializing in the minimally invasive treatment of vertebral fractures, today announced it will initiate...

October 13, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Paris:MKEA)(Euronext: MKEA, FR0010609263), inventor of Cellvizio®, the multidisciplinary optical biopsy platform, today announced that the Haute Autorité de Santé (HAS) - or French...

October 13, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc today announced it will support the inaugural World Thrombosis Day campaign as a Global Partner.

October 10, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it has completed the previously announced sale of shares of its Series A 3.6% convertible preferred stock pursuant to a registered direct offering...

October 10, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its financial results for third-quarter 2014 on Friday, October 24, 2014, before the market opens. The press release and accompanying financial...

October 10, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily single tablet regimen for...

October 10, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative biopharmaceutical company specialized in the development of orphan...

October 10, 2014

WASHINGTON--(BUSINESS WIRE)--ClearFlow announces positive clinical trial results for the reduction of hospital complications after heart surgery.

October 10, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call...

October 10, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced positive results from the phase III study of triptorelin pamoate 11.25 mg (Decapeptyl® 3 months) administered subcutaneously in patients with locally...

October 10, 2014

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Notice is hereby given that the Extraordinary General Meeting (“EGM”) of Meda Aktiebolag, corporate ID 556427-2812 (the “Company”), will be held at 1.00 p.m. on Thursday, November 6, 2014 at...

October 10, 2014

BOSTON--(BUSINESS WIRE)--On October 10, 2014, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is October 21, 2014 and the payable date is October...

October 10, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ:CELG), today announced that results from additional efficacy and safety analyses of OTEZLA® (apremilast) from the ESTEEM...

October 10, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG) today announced that patient-reported health outcomes data for OTEZLA® (apremilast) were presented at the 23rd...

October 10, 2014

LOS ANGELES--(BUSINESS WIRE)--Bud Genius (Symbol: RIGH) is currently negotiating exclusive cannabis product endorsement and licensing deals with celebrities, stars, entertainers, and other household names.

October 10, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on October 9, 2014, the Company’s issued share capital, excluding...

October 10, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today that it will present data from a Phase 1/Phase 2 study evaluating the safety, tolerability and immunogenicity of a single-dose vaccine of Pfizer’s investigational 4-antigen...

October 10, 2014

NEW YORK--(BUSINESS WIRE)--Retrophin, Inc. (NASDAQ:RTRX) today announced the appointment of Jeffrey A. Meckler to the Board of Directors as a fourth independent director. “Jeff brings to our board of directors broad industry experience ranging...

October 10, 2014

BILLERICA, Mass.--(BUSINESS WIRE)--RainDance Technologies, Inc., a genomics tools company simplifying the analysis of complex genetic diseases, announced the appointment of John Luckey as its new Vice President of Product Development.

October 10, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced that clinical and pre-clinical...

October 10, 2014

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has concluded its review...

October 10, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Announces YTD Results for Fiscal Year End 2014

October 10, 2014

FRANKFURT, Germany--(BUSINESS WIRE)--Janssen R&D Ireland (Janssen) today announced the presentation of additional data for the NS3/4A protease inhibitor OLYSIO® (simeprevir) at the Viral Hepatitis Congress (VHC) in Frankfurt, Germany. The...

October 10, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement made by Diagenic ASA (“Diagenic” or the “Company”)(OSE:DIAG) yesterday, 9 October 2014, regarding the Minutes from the Extraordinary General...

October 10, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Reference is made to the stock exchange announcement made by Diagenic ASA (“Diagenic” or the “Company”)(OSE:DIAG) yesterday, 9 October 2014, regarding the Minutes from the Extraordinary General...

October 10, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Aymeric Le Chatelier as Executive Vice President, Chief Financial Officer effective as of 3 November 2014. He will report directly to...

October 9, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) announced today the pricing of its offering of $75,000,000 aggregate principal amount of 2.00% Convertible Senior Notes due 2021 (the “Convertible Notes”) in a private...

October 9, 2014

LONDON--(BUSINESS WIRE)--According to a new peer-reviewed study published in the International Journal of Angiology, a natural extract made from the bark of pine trees may significantly improve the appearance, swelling and discomfort of pregnancy...

October 9, 2014

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences announced that Medicare has issued its final national coverage decision for the company's Cologuard test.

October 9, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, continues to innovate in the treatment of complex deformity with the launch of the SILC™ Fixation System. SILC™ is a low profile...

October 9, 2014

MONONA, Wis.--(BUSINESS WIRE)--SHINE announced today that it executed a term sheet providing for up to $125M with Deerfield. SHINE will use the funds to build a plant to produce more than a quarter of world supply of molybdenum-99.

October 9, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced the publication of the results from the SOLO II Phase 3 clinical trial of ORBACTIV (oritavancin) for injection in the journal Clinical Infectious Diseases....

October 9, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host a quarterly conference call to discuss its third quarter 2014 financial results on Thursday, October 16, 2014, at 7:30 a.m. Central Time. Beginning in the third...

October 9, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien today announced U.S. Food and Drug Administration 510(k) clearance for the Nellcor™ Portable SpO2 Patient Monitoring System (PM10N).

October 9, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fourth quarter and fiscal year ended July 31, 2014, with continued solid year-end gains posted by both Life Sciences and Clinical Labs. Fourth quarter revenues...

October 9, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today it has entered into an agreement providing for up to $125 million of debt and equity financing for SHINE Medical Technologies, Inc. The financing is milestone based with the...

October 9, 2014

WEST CHESTER, Ohio--(BUSINESS WIRE)--The AtriCure ABLATE Post Approval Study enrollment is complete, This is the largest study of its kind to evaluate surgical ablation for treatment of Afib using the AtriCure Synergy Ablation System.

October 9, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori US Trade Mission

October 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S. Food and Drug Administration (FDA) has approved VELCADE® (...